145 related articles for article (PubMed ID: 28830293)
21. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer.
Schmidt ML; Hoffmann L; Kandi M; Møller DS; Poulsen PR
Acta Oncol; 2013 Oct; 52(7):1490-6. PubMed ID: 23905673
[TBL] [Abstract][Full Text] [Related]
22. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
23. The potential for increased tumor control probability in non-small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume.
Fleming C; O'Keeffe S; Dunne M; Armstrong JG; McClean B; Vintro LL
Med Dosim; 2018 Winter; 43(4):352-357. PubMed ID: 29289456
[TBL] [Abstract][Full Text] [Related]
24. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
Wanet M; Delor A; Hanin FX; Ghaye B; Van Maanen A; Remouchamps V; Clermont C; Goossens S; Lee JA; Janssens G; Bol A; Geets X
Strahlenther Onkol; 2017 Oct; 193(10):812-822. PubMed ID: 28733723
[TBL] [Abstract][Full Text] [Related]
25. A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.
Kim M; Phillips MH
Med Phys; 2016 May; 43(5):2153. PubMed ID: 27147327
[TBL] [Abstract][Full Text] [Related]
26. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
Bainbridge HE; Menten MJ; Fast MF; Nill S; Oelfke U; McDonald F
Radiother Oncol; 2017 Nov; 125(2):280-285. PubMed ID: 28987747
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of PET-CT based hypofractionated accelerated dose escalation in oropharyngeal cancers: Final dosimetric results of the VORTIGERN study. (Secondary endpoint of UK NCRI portfolio: MREC No: 08/H0907/127, UKCRN ID 7341).
Chatterjee S; Kelly C; Arunsingh M; Chakrabarty C; Mott J
J Cancer Res Ther; 2015; 11(2):391-6. PubMed ID: 26148606
[TBL] [Abstract][Full Text] [Related]
29. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
[TBL] [Abstract][Full Text] [Related]
30. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
31. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
[TBL] [Abstract][Full Text] [Related]
32. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
33. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
Even AJ; van der Stoep J; Zegers CM; Reymen B; Troost EG; Lambin P; van Elmpt W
Radiother Oncol; 2015 Aug; 116(2):281-6. PubMed ID: 26238010
[TBL] [Abstract][Full Text] [Related]
34. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
[TBL] [Abstract][Full Text] [Related]
35. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
[TBL] [Abstract][Full Text] [Related]
36. Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
Berger T; Petersen JBB; Lindegaard JC; Fokdal LU; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1472-1478. PubMed ID: 28931343
[TBL] [Abstract][Full Text] [Related]
37. The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004-2013.
Christodouleas JP; Hall MD; van der Pas MA; Guo W; Schultheiss TE; Gabriel P
Radiat Oncol; 2017 Jan; 12(1):19. PubMed ID: 28095882
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
[TBL] [Abstract][Full Text] [Related]
39. A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma.
Gains JE; Patel A; Chang YC; Mandeville HC; Smyth G; Stacey C; Talbot J; Wheatley K; Gaze MN
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e154-e162. PubMed ID: 38553363
[TBL] [Abstract][Full Text] [Related]
40. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
